aard: the income statement

MyFinsight

Aardvark Therapeutics, Inc. (AARD)

For the quarter ending 2025-06-30, AARD made $1,488K in revenue. -$14,367K in net income. Net profit margin of -965.52%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	13,145
Credit loss - related party accounts receivable	-
General and administrative expense	2,703
Total operating expenses	15,848
Loss from operations	-15,848
Unrealized (loss) gain on short-term investments	-7
Interest and dividend income	1,488
Total other income, net	1,481
Net loss	-14,367

Earnings per share, diluted	-0.66
Net loss per share of common stock, basic	-0.66
Weighted average number of shares outstanding, basic	21,690,275
Weighted-average shares used in net loss per share calculation, diluted	21,690,275

Unit: Thousand (K) dollars (except for numbers of shares and EPS)